health
Trump Administration Finalizes Rule to End Federal Support for Gender-Affirming Care
Move blocking funds through Medicaid and Chip to make it harder for vulnerable children to get healthcare, experts say
TL;DR
- The Trump administration has finalized a rule to end federal funding for gender-affirming care through Medicaid and Chip, effective October 13.
- Opponents criticize the rule as dangerous, ideologically driven, and harmful to vulnerable children, citing public opposition and a lack of evidence-based justification.
- The US Department of Health and Human Services (HHS) cited international reviews, but critics argue they ignored more recent findings supporting gender-affirming care.
- Legal challenges are expected, and courts have previously ruled against similar actions, citing prejudice and harm.
- If implemented, children on Medicaid and Chip would have six months to transition off medications.
- The administration cites cost and a lack of reliable evidence as reasons for the ban, while advocates stress the care is evidence-based, safe, and potentially life-saving.